Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Antiviral Research|July 5, 2014
Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple stepsMonica M Sauter, Joshua J L Gauger, Curtis R Brandt
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 18, 2007
Ocular drug delivery: molecules, cells, and genesXuyang Liu, Curtis R Brandt, Carol A Rasmussen, et al.
Vaccine|August 16, 2011
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccineJeremy C Jones, Erik W Settles, Curtis R Brandt, et al.
Antimicrobial Agents and Chemotherapy|January 12, 2011
Identification of the minimal active sequence of an anti-influenza virus peptideJeremy C Jones, Erik W Settles, Curtis R Brandt, et al.
Investigative Ophthalmology & Visual Science|April 27, 2011
Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinantAaron W Kolb, Timothy R Schmidt, David W Dyer, et al.
Journal of Virology|April 10, 2015
Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strainsAaron W Kolb, Inna V Larsen, Jacqueline A Cuellar, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 17, 2006
Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entryRadeekorn Akkarawongsa, Amy E Cullinan, Andrew Zinkel, et al.
Pageof 7